Delivery Order SPE2DB20D2104-SPE2DB24FS18M
Award Date 1/23/24
Potential Completion Date 1/24/24
Potential Value $12K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. government's Defense Logistics Agency (DLA) awarded a $13,787.74 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for the treatment of diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,990.95 fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml pharmaceutical product. The award has an ultimate completion date of April 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to...
- This federal contract award, valued at $8,829.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a pharmaceutical product used for diabetes management. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, worth up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat diabetes. The award has a ceiling value of $38,134.68 and a completion date of May 3, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a specialty medication used for managing diabetes. The award has a ceiling value of $7,553.16 and an ultimate completion date of February 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used for diabetes management. The contract has a ceiling value of $19,629.92 and an ultimate completion date of November 5, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The award has a ceiling value of $3,882.50 and a period of performance through April 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml syringes. The contract has a ceiling value of $23,655.03 and an ultimate completion date of March 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC...
- This is a $4,656.39 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price and an ultimate completion date of February 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $8,215.20, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to various government facilities. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...